Index by author

01 April 2009; volume 33, issue 4

A

  1. Alloisio, M.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  2. Álvarez Dobaño, J. M.

    1. Valdés, L. et al "Diagnostic value of interleukin-12 p40 in tuberculous pleural effusions." European Respiratory Journal 33.4 (2009): 816-820. Web. 20 April. 2021.

  3. Ansell, T. K.

    1. Ansell, T. K. et al "Potent bronchodilation and reduced stiffness by relaxant stimuli under dynamic conditions." European Respiratory Journal 33.4 (2009): 844-851. Web. 20 April. 2021.

  4. Antoniou, K. M.

    1. Antoniou, K. M. et al "Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement." European Respiratory Journal 33.4 (2009): 882-896. Web. 20 April. 2021.

B

  1. Baird, J. C.

    1. Mahler, D. A. et al "Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD." European Respiratory Journal 33.4 (2009): 771-777. Web. 20 April. 2021.

  2. Barthélémy, J. C.

    1. Roche, F. et al "Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly." European Respiratory Journal 33.4 (2009): 797-803. Web. 20 April. 2021.

  3. Basner, R. C.

    1. Lederer, D. J. et al "Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea." European Respiratory Journal 33.4 (2009): 793-796. Web. 20 April. 2021.

  4. Basyigit, I.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  5. Berclaz, P. Y.

    1. Jensen, R. et al "Quality control of DL,CO instruments in global clinical trials." European Respiratory Journal 33.4 (2009): 828-834. Web. 20 April. 2021.

  6. Bertrand, M.

    1. Bougault, V. et al "Asthma, airway inflammation and epithelial damage in swimmers and cold-air athletes." European Respiratory Journal 33.4 (2009): 740-746. Web. 20 April. 2021.

  7. Bhattacharya, J.

    1. Lederer, D. J. et al "Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea." European Respiratory Journal 33.4 (2009): 793-796. Web. 20 April. 2021.

  8. Bölkow, D.

    1. Grimminger, F. et al "First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension." European Respiratory Journal 33.4 (2009): 785-792. Web. 20 April. 2021.

  9. Bottoni, E.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  10. Bougault, V.

    1. Bougault, V. et al "Asthma, airway inflammation and epithelial damage in swimmers and cold-air athletes." European Respiratory Journal 33.4 (2009): 740-746. Web. 20 April. 2021.

  11. Boulet, L-P.

    1. Dufour, M-H. et al "Comparative airway response to high- versus low-molecular weight agents in occupational asthma." European Respiratory Journal 33.4 (2009): 734-739. Web. 20 April. 2021.
    2. Bougault, V. et al "Asthma, airway inflammation and epithelial damage in swimmers and cold-air athletes." European Respiratory Journal 33.4 (2009): 740-746. Web. 20 April. 2021.
    3. Boulet, L-P.. "Influence of comorbid conditions on asthma." European Respiratory Journal 33.4 (2009): 897-906. Web. 20 April. 2021.

  12. Brambilla, G.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  13. Brand, P. L. P.

    1. Bush, A., and P. L. P. Brand. " From the authors ." European Respiratory Journal 33.4 (2009): 945. Web. 20 April. 2021.

  14. Bremer, H.

    1. Damjanovic, D. et al "Compliance in sleep apnoea therapy: influence of home care support and pressure mode." European Respiratory Journal 33.4 (2009): 804-811. Web. 20 April. 2021.

  15. Bulut, I.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  16. Bush, A.

    1. Bush, A., and P. L. P. Brand. " From the authors ." European Respiratory Journal 33.4 (2009): 945. Web. 20 April. 2021.

  17. Butcher, S. J.

    1. Butcher, S. J. et al "Relationship between ventilatory constraint and muscle fatigue during exercise in COPD." European Respiratory Journal 33.4 (2009): 763-770. Web. 20 April. 2021.

C

  1. Cariboni, U.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  2. Carlsen, K-H.

    1. Carlsen, K-H.. "Asthma, airway inflammation and epithelial damage in elite athletes." European Respiratory Journal 33.4 (2009): 713-714. Web. 20 April. 2021.

  3. Cavuto, S.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  4. Celle, S.

    1. Roche, F. et al "Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly." European Respiratory Journal 33.4 (2009): 797-803. Web. 20 April. 2021.

  5. Centis, R.

    1. Sotgiu, G. et al "Epidemiology and clinical management of XDR-TB: a systematic review by TBNET." European Respiratory Journal 33.4 (2009): 871-881. Web. 20 April. 2021.

  6. Ceresoli, G. L.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  7. Chu, H. W.

    1. Thaikoottathil, J. V. et al "Cigarette smoke extract reduces VEGF in primary human airway epithelial cells." European Respiratory Journal 33.4 (2009): 835-843. Web. 20 April. 2021.

  8. Cirillo, D.

    1. Sotgiu, G. et al "Epidemiology and clinical management of XDR-TB: a systematic review by TBNET." European Respiratory Journal 33.4 (2009): 871-881. Web. 20 April. 2021.

  9. Clifton, I. J.

    1. Clifton, I. J., A. F. Scarsbrook, and M. F. Muers. "No lung cancer at resection of PET positive lesions: an audit of the lung cancer multidisciplinary team." European Respiratory Journal 33.4 (2009): 941-942. Web. 20 April. 2021.

  10. Collins, D. F.

    1. Butcher, S. J. et al "Relationship between ventilatory constraint and muscle fatigue during exercise in COPD." European Respiratory Journal 33.4 (2009): 763-770. Web. 20 April. 2021.

  11. Coskun, E.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  12. Cotton, M. F.

    1. Marais, B. J., A. C. Hesseling, and M. F. Cotton. "Poverty and tuberculosis: is it truly a simple inverse linear correlation?." European Respiratory Journal 33.4 (2009): 943-944. Web. 20 April. 2021.

  13. Crapo, R.

    1. Jensen, R. et al "Quality control of DL,CO instruments in global clinical trials." European Respiratory Journal 33.4 (2009): 828-834. Web. 20 April. 2021.

D

  1. Dabak, S.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  2. Dahlén, B.

    1. Dahlén, B. et al "Effect of formoterol with or without budesonide in repeated low-dose allergen challenge." European Respiratory Journal 33.4 (2009): 747-753. Web. 20 April. 2021.

  3. Dahlén, S-E.

    1. Dahlén, B. et al "Effect of formoterol with or without budesonide in repeated low-dose allergen challenge." European Respiratory Journal 33.4 (2009): 747-753. Web. 20 April. 2021.

  4. Damjanovic, D.

    1. Damjanovic, D. et al "Compliance in sleep apnoea therapy: influence of home care support and pressure mode." European Respiratory Journal 33.4 (2009): 804-811. Web. 20 April. 2021.

  5. Deveci, F.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  6. Di Rocco, M.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  7. Dufour, M-H.

    1. Dufour, M-H. et al "Comparative airway response to high- versus low-molecular weight agents in occupational asthma." European Respiratory Journal 33.4 (2009): 734-739. Web. 20 April. 2021.

E

  1. Economidou, F.

    1. Antoniou, K. M. et al "Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement." European Respiratory Journal 33.4 (2009): 882-896. Web. 20 April. 2021.

  2. Ekström, T.

    1. Dahlén, B. et al "Effect of formoterol with or without budesonide in repeated low-dose allergen challenge." European Respiratory Journal 33.4 (2009): 747-753. Web. 20 April. 2021.

  3. Errico, V.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

F

  1. Farré, R.

    1. Farré, R., and D. Navajas. "Quality control: a necessary, but sometimes overlooked, tool for improving respiratory medicine." European Respiratory Journal 33.4 (2009): 722-723. Web. 20 April. 2021.

  2. Fernandes, L.

    1. Ansell, T. K. et al "Potent bronchodilation and reduced stiffness by relaxant stimuli under dynamic conditions." European Respiratory Journal 33.4 (2009): 844-851. Web. 20 April. 2021.

  3. Ferrara, G.

    1. Sotgiu, G. et al "Epidemiology and clinical management of XDR-TB: a systematic review by TBNET." European Respiratory Journal 33.4 (2009): 871-881. Web. 20 April. 2021.

  4. Ferraroli, G.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  5. Fidan, F.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  6. Fisseler-Eckhoff, A.

    1. Koschel, D. et al "Hypersensitivity pneumonitis associated with the use of temozolomide." European Respiratory Journal 33.4 (2009): 931-934. Web. 20 April. 2021.

  7. Fluck, A.

    1. Damjanovic, D. et al "Compliance in sleep apnoea therapy: influence of home care support and pressure mode." European Respiratory Journal 33.4 (2009): 804-811. Web. 20 April. 2021.

  8. Frey, R.

    1. Grimminger, F. et al "First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension." European Respiratory Journal 33.4 (2009): 785-792. Web. 20 April. 2021.

G

  1. Garcin, A.

    1. Roche, F. et al "Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly." European Respiratory Journal 33.4 (2009): 797-803. Web. 20 April. 2021.

  2. Gaspoz, J-M.

    1. Roche, F. et al "Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly." European Respiratory Journal 33.4 (2009): 797-803. Web. 20 April. 2021.

  3. Gemicioglu, B.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  4. Ghofrani, H. A.

    1. Woyda, K. et al "Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia." European Respiratory Journal 33.4 (2009): 861-870. Web. 20 April. 2021.

  5. Ghofrani, H.A.

    1. Grimminger, F. et al "First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension." European Respiratory Journal 33.4 (2009): 785-792. Web. 20 April. 2021.

  6. Golpe, A.

    1. Valdés, L. et al "Diagnostic value of interleukin-12 p40 in tuberculous pleural effusions." European Respiratory Journal 33.4 (2009): 816-820. Web. 20 April. 2021.

  7. González Barcala, F. J.

    1. Valdés, L. et al "Diagnostic value of interleukin-12 p40 in tuberculous pleural effusions." European Respiratory Journal 33.4 (2009): 816-820. Web. 20 April. 2021.

  8. Grimminger, F.

    1. Grimminger, F. et al "First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension." European Respiratory Journal 33.4 (2009): 785-792. Web. 20 April. 2021.
    2. Woyda, K. et al "Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia." European Respiratory Journal 33.4 (2009): 861-870. Web. 20 April. 2021.

  9. Günther, A.

    1. Woyda, K. et al "Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia." European Respiratory Journal 33.4 (2009): 861-870. Web. 20 April. 2021.

H

  1. Haas, A. R.

    1. Haas, A. R.. "Infectious complications from full extension endobronchial ultrasound transbronchial needle aspiration." European Respiratory Journal 33.4 (2009): 935-938. Web. 20 April. 2021.

  2. Handzhiev, S.

    1. Koschel, D. et al "Hypersensitivity pneumonitis associated with the use of temozolomide." European Respiratory Journal 33.4 (2009): 931-934. Web. 20 April. 2021.

  3. He, G.

    1. Xu, T. et al "Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice." European Respiratory Journal 33.4 (2009): 852-860. Web. 20 April. 2021.

  4. Henriksson, E.

    1. Dahlén, B. et al "Effect of formoterol with or without budesonide in repeated low-dose allergen challenge." European Respiratory Journal 33.4 (2009): 747-753. Web. 20 April. 2021.

  5. Hesseling, A. C.

    1. Marais, B. J., A. C. Hesseling, and M. F. Cotton. "Poverty and tuberculosis: is it truly a simple inverse linear correlation?." European Respiratory Journal 33.4 (2009): 943-944. Web. 20 April. 2021.

  6. Höffken, G.

    1. Koschel, D. et al "Hypersensitivity pneumonitis associated with the use of temozolomide." European Respiratory Journal 33.4 (2009): 931-934. Web. 20 April. 2021.

  7. Holotiuk, O.

    1. Koschel, D. et al "Hypersensitivity pneumonitis associated with the use of temozolomide." European Respiratory Journal 33.4 (2009): 931-934. Web. 20 April. 2021.

  8. Huibers, M. J. H.

    1. Kotz, D. et al "Efficacy of confronting smokers with airflow limitation for smoking cessation." European Respiratory Journal 33.4 (2009): 754-762. Web. 20 April. 2021.

  9. Huisman, M. V.

    1. Klok, F. A. et al "Smoking patterns in patients following a pulmonary embolism." European Respiratory Journal 33.4 (2009): 942-943. Web. 20 April. 2021.

I

  1. Idzko, M.

    1. Damjanovic, D. et al "Compliance in sleep apnoea therapy: influence of home care support and pressure mode." European Respiratory Journal 33.4 (2009): 804-811. Web. 20 April. 2021.

  2. Ihre, E.

    1. Dahlén, B. et al "Effect of formoterol with or without budesonide in repeated low-dose allergen challenge." European Respiratory Journal 33.4 (2009): 747-753. Web. 20 April. 2021.

  3. Imparato, S.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  4. Incarbone, M. A.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  5. Infante, M.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  6. Inzirillo, F.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  7. Ishizaka, A.

    1. Lederer, D. J. et al "Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea." European Respiratory Journal 33.4 (2009): 793-796. Web. 20 April. 2021.

J

  1. Jelic, S.

    1. Lederer, D. J. et al "Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea." European Respiratory Journal 33.4 (2009): 793-796. Web. 20 April. 2021.

  2. Jennum, P.

    1. Jennum, P., and R. L. Riha. "Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing." European Respiratory Journal 33.4 (2009): 907-914. Web. 20 April. 2021.

  3. Jensen, R.

    1. Jensen, R. et al "Quality control of DL,CO instruments in global clinical trials." European Respiratory Journal 33.4 (2009): 828-834. Web. 20 April. 2021.

  4. Jones, R. L.

    1. Butcher, S. J. et al "Relationship between ventilatory constraint and muscle fatigue during exercise in COPD." European Respiratory Journal 33.4 (2009): 763-770. Web. 20 April. 2021.

  5. Jörgensen, L.

    1. Dahlén, B. et al "Effect of formoterol with or without budesonide in repeated low-dose allergen challenge." European Respiratory Journal 33.4 (2009): 747-753. Web. 20 April. 2021.

K

  1. Kalomenidis, I.

    1. Porfyridis, I. et al "Etanercept-induced pleuropericardial lupus-like syndrome." European Respiratory Journal 33.4 (2009): 939-941. Web. 20 April. 2021.

  2. Karakis, G.Pasaoglu

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  3. Kaynar, H.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  4. Klok, F. A.

    1. Klok, F. A. et al "Smoking patterns in patients following a pulmonary embolism." European Respiratory Journal 33.4 (2009): 942-943. Web. 20 April. 2021.

  5. Kobashi, Y.

    1. Kobashi, Y. et al "Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice." European Respiratory Journal 33.4 (2009): 812-815. Web. 20 April. 2021.

  6. Koebrich, S.

    1. Woyda, K. et al "Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia." European Respiratory Journal 33.4 (2009): 861-870. Web. 20 April. 2021.

  7. Koschel, D.

    1. Koschel, D. et al "Hypersensitivity pneumonitis associated with the use of temozolomide." European Respiratory Journal 33.4 (2009): 931-934. Web. 20 April. 2021.

  8. Kotz, D.

    1. Kotz, D. et al "Efficacy of confronting smokers with airflow limitation for smoking cessation." European Respiratory Journal 33.4 (2009): 754-762. Web. 20 April. 2021.

  9. Kraemer, W. J.

    1. Mahler, D. A. et al "Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD." European Respiratory Journal 33.4 (2009): 771-777. Web. 20 April. 2021.

  10. Kurt, E.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

L

  1. Lagerquist, O.

    1. Butcher, S. J. et al "Relationship between ventilatory constraint and muscle fatigue during exercise in COPD." European Respiratory Journal 33.4 (2009): 763-770. Web. 20 April. 2021.

  2. Lange, C.

    1. Sotgiu, G. et al "Epidemiology and clinical management of XDR-TB: a systematic review by TBNET." European Respiratory Journal 33.4 (2009): 871-881. Web. 20 April. 2021.

  3. Lantz, A-S.

    1. Dahlén, B. et al "Effect of formoterol with or without budesonide in repeated low-dose allergen challenge." European Respiratory Journal 33.4 (2009): 747-753. Web. 20 April. 2021.

  4. Larsson, K.

    1. Dahlén, B. et al "Effect of formoterol with or without budesonide in repeated low-dose allergen challenge." European Respiratory Journal 33.4 (2009): 747-753. Web. 20 April. 2021.

  5. Lederer, D. J.

    1. Lederer, D. J. et al "Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea." European Respiratory Journal 33.4 (2009): 793-796. Web. 20 April. 2021.

  6. Lee, Y-C.

    1. Perng, D-W. et al "Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD." European Respiratory Journal 33.4 (2009): 778-784. Web. 20 April. 2021.

  7. Lemière, C.

    1. Dufour, M-H. et al "Comparative airway response to high- versus low-molecular weight agents in occupational asthma." European Respiratory Journal 33.4 (2009): 734-739. Web. 20 April. 2021.

  8. Leucht, V.

    1. Koschel, D. et al "Hypersensitivity pneumonitis associated with the use of temozolomide." European Respiratory Journal 33.4 (2009): 931-934. Web. 20 April. 2021.

  9. Leyk, M.

    1. Jensen, R. et al "Quality control of DL,CO instruments in global clinical trials." European Respiratory Journal 33.4 (2009): 828-834. Web. 20 April. 2021.

  10. Li, K.

    1. Xu, T. et al "Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice." European Respiratory Journal 33.4 (2009): 852-860. Web. 20 April. 2021.

  11. Liu, L-Y.

    1. Perng, D-W. et al "Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD." European Respiratory Journal 33.4 (2009): 778-784. Web. 20 April. 2021.

  12. Lutman, R. F.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

M

  1. Mahler, D. A.

    1. Mahler, D. A. et al "Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD." European Respiratory Journal 33.4 (2009): 771-777. Web. 20 April. 2021.

  2. Marais, B. J.

    1. Marais, B. J., A. C. Hesseling, and M. F. Cotton. "Poverty and tuberculosis: is it truly a simple inverse linear correlation?." European Respiratory Journal 33.4 (2009): 943-944. Web. 20 April. 2021.

  3. Marciniuk, D. D.

    1. Butcher, S. J. et al "Relationship between ventilatory constraint and muscle fatigue during exercise in COPD." European Respiratory Journal 33.4 (2009): 763-770. Web. 20 April. 2021.

  4. Margaritopoulos, G.

    1. Antoniou, K. M. et al "Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement." European Respiratory Journal 33.4 (2009): 882-896. Web. 20 April. 2021.

  5. Martin, R. J.

    1. Thaikoottathil, J. V. et al "Cigarette smoke extract reduces VEGF in primary human airway epithelial cells." European Respiratory Journal 33.4 (2009): 835-843. Web. 20 April. 2021.

  6. Matteelli, A.

    1. Sotgiu, G. et al "Epidemiology and clinical management of XDR-TB: a systematic review by TBNET." European Respiratory Journal 33.4 (2009): 871-881. Web. 20 April. 2021.

  7. Maudoux, D.

    1. Roche, F. et al "Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly." European Respiratory Journal 33.4 (2009): 797-803. Web. 20 April. 2021.

  8. McFawn, P. K.

    1. Ansell, T. K. et al "Potent bronchodilation and reduced stiffness by relaxant stimuli under dynamic conditions." European Respiratory Journal 33.4 (2009): 844-851. Web. 20 April. 2021.

  9. Metintas, S.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  10. Michelakis, E. D.

    1. Michelakis, E. D.. "Soluble guanylate cyclase stimulators as a potential therapy for PAH: enthusiasm, pragmatism and concern." European Respiratory Journal 33.4 (2009): 717-721. Web. 20 April. 2021.

  11. Migliori, G. B.

    1. Sotgiu, G. et al "Epidemiology and clinical management of XDR-TB: a systematic review by TBNET." European Respiratory Journal 33.4 (2009): 871-881. Web. 20 April. 2021.

  12. Minuti, F.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  13. Mitchell, H. W.

    1. Ansell, T. K. et al "Potent bronchodilation and reduced stiffness by relaxant stimuli under dynamic conditions." European Respiratory Journal 33.4 (2009): 844-851. Web. 20 April. 2021.

  14. Miyashita, N.

    1. Kobashi, Y. et al "Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice." European Respiratory Journal 33.4 (2009): 812-815. Web. 20 April. 2021.

  15. Morenghi, E.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  16. Moro-Sibilot, D.

    1. Sculier, J-P., and D. Moro-Sibilot. "First- and second-line therapy for advanced nonsmall cell lung cancer." European Respiratory Journal 33.4 (2009): 915-930. Web. 20 April. 2021.

  17. Morty, R. E.

    1. Woyda, K. et al "Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia." European Respiratory Journal 33.4 (2009): 861-870. Web. 20 April. 2021.

  18. Mos, I. C. M.

    1. Klok, F. A. et al "Smoking patterns in patients following a pulmonary embolism." European Respiratory Journal 33.4 (2009): 942-943. Web. 20 April. 2021.

  19. Mouri, K.

    1. Kobashi, Y. et al "Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice." European Respiratory Journal 33.4 (2009): 812-815. Web. 20 April. 2021.

  20. Muchmore, D.

    1. Jensen, R. et al "Quality control of DL,CO instruments in global clinical trials." European Respiratory Journal 33.4 (2009): 828-834. Web. 20 April. 2021.

  21. Mück, W.

    1. Grimminger, F. et al "First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension." European Respiratory Journal 33.4 (2009): 785-792. Web. 20 April. 2021.

  22. Muers, M. F.

    1. Clifton, I. J., A. F. Scarsbrook, and M. F. Muers. "No lung cancer at resection of PET positive lesions: an audit of the lung cancer multidisciplinary team." European Respiratory Journal 33.4 (2009): 941-942. Web. 20 April. 2021.

  23. Müller-Quernheim, J.

    1. Damjanovic, D. et al "Compliance in sleep apnoea therapy: influence of home care support and pressure mode." European Respiratory Journal 33.4 (2009): 804-811. Web. 20 April. 2021.

  24. Mungan, D.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  25. Murray, J. A.

    1. Mahler, D. A. et al "Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD." European Respiratory Journal 33.4 (2009): 771-777. Web. 20 April. 2021.

N

  1. Navajas, D.

    1. Farré, R., and D. Navajas. "Quality control: a necessary, but sometimes overlooked, tool for improving respiratory medicine." European Respiratory Journal 33.4 (2009): 722-723. Web. 20 April. 2021.

  2. Noble, P. B.

    1. Ansell, T. K. et al "Potent bronchodilation and reduced stiffness by relaxant stimuli under dynamic conditions." European Respiratory Journal 33.4 (2009): 844-851. Web. 20 April. 2021.

O

  1. Obase, Y.

    1. Kobashi, Y. et al "Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice." European Respiratory Journal 33.4 (2009): 812-815. Web. 20 April. 2021.

  2. Oguzulgen, K.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  3. Oka, M.

    1. Kobashi, Y. et al "Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice." European Respiratory Journal 33.4 (2009): 812-815. Web. 20 April. 2021.

  4. Onbasi, K.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  5. Ozkurt, S.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

P

  1. Papagiannis, A.

    1. Papagiannis, A.. "The Greeks have a word for it." European Respiratory Journal 33.4 (2009): 946. Web. 20 April. 2021.

  2. Parkes, G.

    1. Soriano, J. B., and G. Parkes. "Remember elephants and icebergs… “Your lung function should be here, but it is there!”." European Respiratory Journal 33.4 (2009): 715-716. Web. 20 April. 2021.

  3. Payne, D.

    1. Schultz, A., and D. Payne. "Danger of using an unreliable classification system for preschool wheeze." European Respiratory Journal 33.4 (2009): 944-945. Web. 20 April. 2021.

  4. Penela, P.

    1. Valdés, L. et al "Diagnostic value of interleukin-12 p40 in tuberculous pleural effusions." European Respiratory Journal 33.4 (2009): 816-820. Web. 20 April. 2021.

  5. Perng, D-W.

    1. Perng, D-W. et al "Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD." European Respiratory Journal 33.4 (2009): 778-784. Web. 20 April. 2021.

  6. Petersen, S. R.

    1. Butcher, S. J. et al "Relationship between ventilatory constraint and muscle fatigue during exercise in COPD." European Respiratory Journal 33.4 (2009): 763-770. Web. 20 April. 2021.

  7. Picard-Kossovsky, M.

    1. Roche, F. et al "Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly." European Respiratory Journal 33.4 (2009): 797-803. Web. 20 April. 2021.

  8. Pichot, V.

    1. Roche, F. et al "Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly." European Respiratory Journal 33.4 (2009): 797-803. Web. 20 April. 2021.

  9. Porfyridis, I.

    1. Porfyridis, I. et al "Etanercept-induced pleuropericardial lupus-like syndrome." European Respiratory Journal 33.4 (2009): 939-941. Web. 20 April. 2021.

  10. Prince, P.

    1. Dufour, M-H. et al "Comparative airway response to high- versus low-molecular weight agents in occupational asthma." European Respiratory Journal 33.4 (2009): 734-739. Web. 20 April. 2021.

  11. Psallidas, I.

    1. Porfyridis, I. et al "Etanercept-induced pleuropericardial lupus-like syndrome." European Respiratory Journal 33.4 (2009): 939-941. Web. 20 April. 2021.

  12. Pullamsetti, S. S.

    1. Woyda, K. et al "Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia." European Respiratory Journal 33.4 (2009): 861-870. Web. 20 April. 2021.

Q

  1. Qiao, J.

    1. Xu, T. et al "Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice." European Respiratory Journal 33.4 (2009): 852-860. Web. 20 April. 2021.

R

  1. Ravasi, G.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  2. Reiss, I.

    1. Woyda, K. et al "Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia." European Respiratory Journal 33.4 (2009): 861-870. Web. 20 April. 2021.

  3. Richardson, M. D.

    1. Sotgiu, G. et al "Epidemiology and clinical management of XDR-TB: a systematic review by TBNET." European Respiratory Journal 33.4 (2009): 871-881. Web. 20 April. 2021.

  4. Riha, R. L.

    1. Jennum, P., and R. L. Riha. "Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing." European Respiratory Journal 33.4 (2009): 907-914. Web. 20 April. 2021.

  5. Rino, J. G.

    1. Thaikoottathil, J. V. et al "Cigarette smoke extract reduces VEGF in primary human airway epithelial cells." European Respiratory Journal 33.4 (2009): 835-843. Web. 20 April. 2021.

  6. Roche, F.

    1. Roche, F. et al "Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly." European Respiratory Journal 33.4 (2009): 797-803. Web. 20 April. 2021.

  7. Roussos, C.

    1. Porfyridis, I. et al "Etanercept-induced pleuropericardial lupus-like syndrome." European Respiratory Journal 33.4 (2009): 939-941. Web. 20 April. 2021.

  8. Rudloff, S.

    1. Woyda, K. et al "Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia." European Respiratory Journal 33.4 (2009): 861-870. Web. 20 April. 2021.

  9. Ruesch-Gerdes, S.

    1. Sotgiu, G. et al "Epidemiology and clinical management of XDR-TB: a systematic review by TBNET." European Respiratory Journal 33.4 (2009): 871-881. Web. 20 April. 2021.

  10. Rühlmann, A.

    1. Woyda, K. et al "Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia." European Respiratory Journal 33.4 (2009): 861-870. Web. 20 April. 2021.

S

  1. Sahan, S.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  2. Sahin, U.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  3. San José, E.

    1. Valdés, L. et al "Diagnostic value of interleukin-12 p40 in tuberculous pleural effusions." European Respiratory Journal 33.4 (2009): 816-820. Web. 20 April. 2021.

  4. Scarsbrook, A. F.

    1. Clifton, I. J., A. F. Scarsbrook, and M. F. Muers. "No lung cancer at resection of PET positive lesions: an audit of the lung cancer multidisciplinary team." European Respiratory Journal 33.4 (2009): 941-942. Web. 20 April. 2021.

  5. Schermuly, R. T.

    1. Grimminger, F. et al "First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension." European Respiratory Journal 33.4 (2009): 785-792. Web. 20 April. 2021.
    2. Woyda, K. et al "Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia." European Respiratory Journal 33.4 (2009): 861-870. Web. 20 April. 2021.

  6. Schultz, A.

    1. Schultz, A., and D. Payne. "Danger of using an unreliable classification system for preschool wheeze." European Respiratory Journal 33.4 (2009): 944-945. Web. 20 April. 2021.

  7. Sculier, J-P.

    1. Sculier, J-P., and D. Moro-Sibilot. "First- and second-line therapy for advanced nonsmall cell lung cancer." European Respiratory Journal 33.4 (2009): 915-930. Web. 20 April. 2021.

  8. Seeger, W.

    1. Woyda, K. et al "Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia." European Respiratory Journal 33.4 (2009): 861-870. Web. 20 April. 2021.

  9. Sforza, E.

    1. Roche, F. et al "Association between C-reactive protein and unrecognised sleep-disordered breathing in the elderly." European Respiratory Journal 33.4 (2009): 797-803. Web. 20 April. 2021.

  10. Siafakas, N. M.

    1. Antoniou, K. M. et al "Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement." European Respiratory Journal 33.4 (2009): 882-896. Web. 20 April. 2021.

  11. Skedinger, M.

    1. Dahlén, B. et al "Effect of formoterol with or without budesonide in repeated low-dose allergen challenge." European Respiratory Journal 33.4 (2009): 747-753. Web. 20 April. 2021.

  12. Soriano, J. B.

    1. Soriano, J. B., and G. Parkes. "Remember elephants and icebergs… “Your lung function should be here, but it is there!”." European Respiratory Journal 33.4 (2009): 715-716. Web. 20 April. 2021.

  13. Sorichter, S.

    1. Damjanovic, D. et al "Compliance in sleep apnoea therapy: influence of home care support and pressure mode." European Respiratory Journal 33.4 (2009): 804-811. Web. 20 April. 2021.

  14. Sotgiu, G.

    1. Sotgiu, G. et al "Epidemiology and clinical management of XDR-TB: a systematic review by TBNET." European Respiratory Journal 33.4 (2009): 871-881. Web. 20 April. 2021.

  15. Spanevello, A.

    1. Sotgiu, G. et al "Epidemiology and clinical management of XDR-TB: a systematic review by TBNET." European Respiratory Journal 33.4 (2009): 871-881. Web. 20 April. 2021.

  16. St-Laurent, J.

    1. Bougault, V. et al "Asthma, airway inflammation and epithelial damage in swimmers and cold-air athletes." European Respiratory Journal 33.4 (2009): 740-746. Web. 20 April. 2021.

  17. Stathopoulos, G. T.

    1. Porfyridis, I. et al "Etanercept-induced pleuropericardial lupus-like syndrome." European Respiratory Journal 33.4 (2009): 939-941. Web. 20 April. 2021.

  18. Stratakos, G.

    1. Porfyridis, I. et al "Etanercept-induced pleuropericardial lupus-like syndrome." European Respiratory Journal 33.4 (2009): 939-941. Web. 20 April. 2021.

  19. Su, K-C.

    1. Perng, D-W. et al "Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD." European Respiratory Journal 33.4 (2009): 778-784. Web. 20 April. 2021.

  20. Sugiu, T.

    1. Kobashi, Y. et al "Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice." European Respiratory Journal 33.4 (2009): 812-815. Web. 20 April. 2021.

T

  1. Tamsma, J. T.

    1. Klok, F. A. et al "Smoking patterns in patients following a pulmonary embolism." European Respiratory Journal 33.4 (2009): 942-943. Web. 20 April. 2021.

  2. Tao, C-W.

    1. Perng, D-W. et al "Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD." European Respiratory Journal 33.4 (2009): 778-784. Web. 20 April. 2021.

  3. Thaikoottathil, J. V.

    1. Thaikoottathil, J. V. et al "Cigarette smoke extract reduces VEGF in primary human airway epithelial cells." European Respiratory Journal 33.4 (2009): 835-843. Web. 20 April. 2021.

  4. Thamm, M.

    1. Grimminger, F. et al "First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension." European Respiratory Journal 33.4 (2009): 785-792. Web. 20 April. 2021.

  5. Tian, Y.

    1. Xu, T. et al "Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice." European Respiratory Journal 33.4 (2009): 852-860. Web. 20 April. 2021.

  6. Torri, V.

    1. Infante, M. et al "Differential diagnosis and management of focal ground-glass opacities." European Respiratory Journal 33.4 (2009): 821-827. Web. 20 April. 2021.

  7. Toungoussova, O.

    1. Sotgiu, G. et al "Epidemiology and clinical management of XDR-TB: a systematic review by TBNET." European Respiratory Journal 33.4 (2009): 871-881. Web. 20 April. 2021.

  8. Tsai, C-C.

    1. Perng, D-W. et al "Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD." European Respiratory Journal 33.4 (2009): 778-784. Web. 20 April. 2021.

  9. Turmel, J.

    1. Bougault, V. et al "Asthma, airway inflammation and epithelial damage in swimmers and cold-air athletes." European Respiratory Journal 33.4 (2009): 740-746. Web. 20 April. 2021.

U

  1. Unger, S.

    1. Grimminger, F. et al "First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension." European Respiratory Journal 33.4 (2009): 785-792. Web. 20 April. 2021.

  2. Uzaslan, E.Kunt

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

V

  1. Valdés, L.

    1. Valdés, L. et al "Diagnostic value of interleukin-12 p40 in tuberculous pleural effusions." European Respiratory Journal 33.4 (2009): 816-820. Web. 20 April. 2021.

  2. Valle, J. M.

    1. Valdés, L. et al "Diagnostic value of interleukin-12 p40 in tuberculous pleural effusions." European Respiratory Journal 33.4 (2009): 816-820. Web. 20 April. 2021.

  3. van Kralingen, K. W.

    1. Klok, F. A. et al "Smoking patterns in patients following a pulmonary embolism." European Respiratory Journal 33.4 (2009): 942-943. Web. 20 April. 2021.

  4. van Schayck, O. C. P.

    1. Kotz, D. et al "Efficacy of confronting smokers with airflow limitation for smoking cessation." European Respiratory Journal 33.4 (2009): 754-762. Web. 20 April. 2021.

  5. Vassilakopoulos, T.

    1. Porfyridis, I. et al "Etanercept-induced pleuropericardial lupus-like syndrome." European Respiratory Journal 33.4 (2009): 939-941. Web. 20 April. 2021.

  6. Voswinckel, R.

    1. Grimminger, F. et al "First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension." European Respiratory Journal 33.4 (2009): 785-792. Web. 20 April. 2021.

W

  1. Wang, H.

    1. Xu, T. et al "Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice." European Respiratory Journal 33.4 (2009): 852-860. Web. 20 April. 2021.

  2. Wang, J.

    1. Xu, T. et al "Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice." European Respiratory Journal 33.4 (2009): 852-860. Web. 20 April. 2021.

  3. Ward, J.

    1. Mahler, D. A. et al "Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD." European Respiratory Journal 33.4 (2009): 771-777. Web. 20 April. 2021.

  4. Waterman, L. A.

    1. Mahler, D. A. et al "Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD." European Respiratory Journal 33.4 (2009): 771-777. Web. 20 April. 2021.

  5. Weimann, G.

    1. Grimminger, F. et al "First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension." European Respiratory Journal 33.4 (2009): 785-792. Web. 20 April. 2021.

  6. Weinberger, A.

    1. Thaikoottathil, J. V. et al "Cigarette smoke extract reduces VEGF in primary human airway epithelial cells." European Respiratory Journal 33.4 (2009): 835-843. Web. 20 April. 2021.

  7. Weissmann, N.

    1. Grimminger, F. et al "First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension." European Respiratory Journal 33.4 (2009): 785-792. Web. 20 April. 2021.
    2. Woyda, K. et al "Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia." European Respiratory Journal 33.4 (2009): 861-870. Web. 20 April. 2021.

  8. Wensing, G.

    1. Grimminger, F. et al "First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension." European Respiratory Journal 33.4 (2009): 785-792. Web. 20 April. 2021.

  9. Wesseling, G.

    1. Kotz, D. et al "Efficacy of confronting smokers with airflow limitation for smoking cessation." European Respiratory Journal 33.4 (2009): 754-762. Web. 20 April. 2021.

  10. West, A. R.

    1. Ansell, T. K. et al "Potent bronchodilation and reduced stiffness by relaxant stimuli under dynamic conditions." European Respiratory Journal 33.4 (2009): 844-851. Web. 20 April. 2021.

  11. Woyda, K.

    1. Woyda, K. et al "Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxia." European Respiratory Journal 33.4 (2009): 861-870. Web. 20 April. 2021.

X

  1. Xu, T.

    1. Xu, T. et al "Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice." European Respiratory Journal 33.4 (2009): 852-860. Web. 20 April. 2021.

Y

  1. Yildiz, F.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

  2. Yorgancioglu, A.

    1. Kurt, E. et al "Prevalence and Risk Factors of Allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults." European Respiratory Journal 33.4 (2009): 724-733. Web. 20 April. 2021.

Z

  1. Zdunek, J.

    1. Thaikoottathil, J. V. et al "Cigarette smoke extract reduces VEGF in primary human airway epithelial cells." European Respiratory Journal 33.4 (2009): 835-843. Web. 20 April. 2021.

  2. Zellweger, J-P.

    1. Sotgiu, G. et al "Epidemiology and clinical management of XDR-TB: a systematic review by TBNET." European Respiratory Journal 33.4 (2009): 871-881. Web. 20 April. 2021.

  3. Zhang, X.

    1. Mahler, D. A. et al "Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD." European Respiratory Journal 33.4 (2009): 771-777. Web. 20 April. 2021.

  4. Zhao, L.

    1. Xu, T. et al "Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice." European Respiratory Journal 33.4 (2009): 852-860. Web. 20 April. 2021.
Back to top
European Respiratory Journal: 33 (4)

Search Within This Issue

Jump to

Manage Table of content Alerts